NMPA Approval

Sulfamethoxazole,Sulfadiazine and Trimethoprim Tablets

Approval Number

国药准字H14023739

Company山西太原药业有限公司

Registration Date

March 25, 2025

Drug Information

Generic Name

联磺甲氧苄啶片

Dosage Form

片剂

Strength

磺胺甲恶唑0.2g、磺胺嘧啶0.2g、甲氧苄啶80mg。

Drug Type

化学药品

Registration Date

March 25, 2025

Company Information

Applicant Company

Company Name山西太原药业有限公司

Company Address

山西省太原市晋源区化工路22号

Manufacturing Company

Company Name山西太原药业有限公司

Company Address

山西省太原市晋源区化工路22号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

联磺甲氧苄啶片 - NMPA 批准文号 | MedPath